Shenzhen Liewen Technology Co., Ltd – Trademark Portfolio

Entity Type: 99

Shenzhen Liewen Technology Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include OXINYRA. The owner is based in Shenzhen City.

306, Lane 2, Shuidou Xinwei Vil, Yousong

Community, Longhua St, Longhua Dist,

Shenzhen City 518000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

OXINYRA
OXINYRA
Registered 2024

Trademark Classifications

Shenzhen Liewen Technology Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Shenzhen Liewen Technology Co., Ltd have?

Shenzhen Liewen Technology Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhen Liewen Technology Co., Ltd file in?

Shenzhen Liewen Technology Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Shenzhen Liewen Technology Co., Ltd's most well-known trademarks?

Shenzhen Liewen Technology Co., Ltd's registered trademark portfolio includes well-known marks such as OXINYRA. These are among 1 currently registered trademark in the portfolio.

What is Shenzhen Liewen Technology Co., Ltd's trademark registration success rate?

Shenzhen Liewen Technology Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.